Attention deficit hyperactivity disorder and Diplopia

Summary:

Diplopia is found among people with Attention deficit hyperactivity disorder, especially for people who are female, 10-19 old.

The study analyzes which people have Diplopia with Attention deficit hyperactivity disorder. It is created by eHealthMe based on reports of 104 people who have Attention deficit hyperactivity disorder from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Attention deficit hyperactivity disorder?

Attention deficit hyperactivity disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness) is found to be associated with 610 drugs and 1,393 conditions by eHealthMe. Check the latest studies of Attention deficit hyperactivity disorder.

What is Diplopia?

Diplopia (double vision) is found to be associated with 1,432 drugs and 1,892 conditions by eHealthMe. Check the latest studies of Diplopia.

On Jul, 17, 2026

104 people who have Attention Deficit Hyperactivity Disorder and Diplopia are studied.

Would you have Diplopia when you have Attention deficit hyperactivity disorder?

Gender of people who have Attention deficit hyperactivity disorder and experienced Diplopia *:

Click here to view

Age of people who have Attention deficit hyperactivity disorder and experienced Diplopia *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Diplopia?

- Check whether Diplopia is associated with a drug or a condition

Related publications that referenced our studies

Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
Kocamaz, M., & Karadag, O., "Topiramate-Induced Acute Myopia, Diplopia, and Photosensitivity: A Case Report", Beyoglu Eye Journal, 2019 Jan .
Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
Kocamaz, M., & Karadag, O., "Topiramate-Induced Acute Myopia, Diplopia, and Photosensitivity: A Case Report", Beyoglu Eye Journal, 2019 Jan .

Related studies:

Treatments, associated drugs and conditions:

Attention deficit hyperactivity disorder (120,336 reports)
Diplopia (32,465 reports)

All the drugs that are associated with Diplopia:

Diplopia (1,432 drugs)

All the conditions that are associated with Diplopia:

Diplopia (1,892 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Diplopia and Attention deficit hyperactivity disorder, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.